MIRXES-B Unveils Approximately 12% Discounted Share Placement Aiming to Raise Around HKD670 Million
Company Overview: MIRXES-B, a biotechnology firm focused on early cancer detection, has announced a share placement agreement.
Share Placement Details: The company plans to issue approximately 21.888 million new shares at HKD32.5 each, representing about 7.34% of its enlarged issued share capital.
Financial Impact: The share placement is expected to raise around HKD711 million, with net proceeds estimated at HKD673 million.
Market Performance: Following the announcement, MIRXES-B's stock experienced a decline of 5.911%, with significant short selling activity reported.
Trade with 70% Backtested Accuracy
Analyst Views on 02629
No data
About the author
<Midday Update> HSI Declines by 304 Points; HSTI Falls by 25 Points; LI AUTO Rises Over 5%; REALORD GROUP, ND PAPER, SANY INT'L, BOC AVIATION, BJ ENT WATER Reach New Peaks
Market Performance: The Hang Seng Index (HSI) fell by 304 points (1.1%) to 26,580, while the Hang Seng Tech Index (HSTI) and the Hang Seng China Enterprises Index (HSCEI) also experienced declines.
Active Heavyweights: Major stocks like Alibaba, Meituan, and Ping An saw significant drops, with Alibaba closing down 2.6% and Meituan down 1.9%, while Xiaomi was an exception, rising by 1.5%.
Notable Movers: LI Auto surged by 5.3%, while AIA and HSBC Holdings dropped by 4.9% and 3.3%, respectively, indicating mixed performance among HSI and HSCEI constituents.
High Performers and Decliners: In the HSMI and HSSI, INNOCARE rose by 11.1%, while MIRXES-B fell by 10.4%, showcasing a diverse range of stock movements within the market.
MIRXES-B Unveils Approximately 12% Discounted Share Placement Aiming to Raise Around HKD670 Million
Company Overview: MIRXES-B, a biotechnology firm focused on early cancer detection, has announced a share placement agreement.
Share Placement Details: The company plans to issue approximately 21.888 million new shares at HKD32.5 each, representing about 7.34% of its enlarged issued share capital.
Financial Impact: The share placement is expected to raise around HKD711 million, with net proceeds estimated at HKD673 million.
Market Performance: Following the announcement, MIRXES-B's stock experienced a decline of 5.911%, with significant short selling activity reported.
<Daily Summary> HSI Ends at 26,446, Gaining 58 Points; HSTI Finishes at 6,043, Up 54 Points; WUXI BIO Surges Over 6%; BABA, NONGFU SPRING, NTES, TRANSTHERA-B, BAYZED HEALTH Reach New Peaks; Market Activity Increases
Market Performance: The HSI rose by 58 points (0.2%) to 26,446, while the HSTI increased by 54 points (0.9%) to 6,043, and the HSCEI gained 19 points (0.2%) to 9,384, with a total market turnover of $290.19 billion.
Active Heavyweights: Notable stock movements included BABA (+2.3% to $154.6), XIAOMI (+1.9% to $56.2), and LI AUTO (+4.6% to $97.55), while POP MART saw a significant decline of 6.4% to $259.
High Performers: Among HSMI & HSSI constituents, TRANSTHERA-B surged by 115.6% to $415, BAYZED HEALTH rose by 50.6% to $10.24, and BRAINAURORA-B increased by 34.9% to $10.12, all hitting new highs.
Short Selling Data: The short selling ratios for major stocks varied, with NONGFU SPRING at 27.538% and BYD COMPANY at 9.979%, indicating significant market interest and activity.
<Midday Update> HSI Ends Midday at 26,463, Gaining 75 Points; HSTI Reaches 6,055, Up 66 Points; POP MART Falls More Than 7%; BABA, NTES, BAYZED HEALTH, and BRAINAURORA-B, TRANSTHERA-B Achieve New Highs
Market Performance: The HSI rose 75 points (0.3%) to 26,463, while the HSTI increased by 66 points (1.1%) to 6,055, and the HSCEI gained 31 points (0.3%) to 9,396.
Active Heavyweights: Notable stock movements included BABA (+2.8% to $155.4), XIAOMI (+1.2% to $55.8), and WUXI BIO (+5.5% to $38.48), while POP MART saw a significant decline of 7.2% to $257.
Short Selling Insights: BABA had a short selling ratio of 21.604% with $5.60B in short sales, while NTES had a high short selling ratio of 32.026% but still rose 1.5% to $240.
High Performers: BAYZED HEALTH surged by 40.3% to $9.54, BRAINAURORA-B increased by 36.3% to $10.22, and TRANSTHERA-B rose by 33.6% to $257.2, all hitting new highs.
CICC Identifies Stocks Expected to Qualify for Southbound Trading (Table)
Stock Predictions: CICC has listed stocks that may be included or excluded from the Hang Seng Composite Index, impacting their eligibility for Stock Connect investment.
Short Selling Data: Several companies, including China Foods and Country Garden, are experiencing significant short selling activity with varying ratios.
Stock Performance: The article highlights the percentage changes in stock prices for various companies, indicating both gains and losses.
Market Context: The information is relevant as it reflects current market trends and investor sentiment towards specific stocks in Hong Kong.
<Midday Update> HSI Declines by 304 Points; HSTI Falls by 25 Points; LI AUTO Rises Over 5%; REALORD GROUP, ND PAPER, SANY INT'L, BOC AVIATION, BJ ENT WATER Reach New Peaks
Market Performance: The Hang Seng Index (HSI) fell by 304 points (1.1%) to 26,580, while the Hang Seng Tech Index (HSTI) and the Hang Seng China Enterprises Index (HSCEI) also experienced declines.
Active Heavyweights: Major stocks like Alibaba, Meituan, and Ping An saw significant drops, with Alibaba closing down 2.6% and Meituan down 1.9%, while Xiaomi was an exception, rising by 1.5%.
Notable Movers: LI Auto surged by 5.3%, while AIA and HSBC Holdings dropped by 4.9% and 3.3%, respectively, indicating mixed performance among HSI and HSCEI constituents.
High Performers and Decliners: In the HSMI and HSSI, INNOCARE rose by 11.1%, while MIRXES-B fell by 10.4%, showcasing a diverse range of stock movements within the market.
MIRXES-B Unveils Approximately 12% Discounted Share Placement Aiming to Raise Around HKD670 Million
Company Overview: MIRXES-B, a biotechnology firm focused on early cancer detection, has announced a share placement agreement.
Share Placement Details: The company plans to issue approximately 21.888 million new shares at HKD32.5 each, representing about 7.34% of its enlarged issued share capital.
Financial Impact: The share placement is expected to raise around HKD711 million, with net proceeds estimated at HKD673 million.
Market Performance: Following the announcement, MIRXES-B's stock experienced a decline of 5.911%, with significant short selling activity reported.
<Daily Summary> HSI Ends at 26,446, Gaining 58 Points; HSTI Finishes at 6,043, Up 54 Points; WUXI BIO Surges Over 6%; BABA, NONGFU SPRING, NTES, TRANSTHERA-B, BAYZED HEALTH Reach New Peaks; Market Activity Increases
Market Performance: The HSI rose by 58 points (0.2%) to 26,446, while the HSTI increased by 54 points (0.9%) to 6,043, and the HSCEI gained 19 points (0.2%) to 9,384, with a total market turnover of $290.19 billion.
Active Heavyweights: Notable stock movements included BABA (+2.3% to $154.6), XIAOMI (+1.9% to $56.2), and LI AUTO (+4.6% to $97.55), while POP MART saw a significant decline of 6.4% to $259.
High Performers: Among HSMI & HSSI constituents, TRANSTHERA-B surged by 115.6% to $415, BAYZED HEALTH rose by 50.6% to $10.24, and BRAINAURORA-B increased by 34.9% to $10.12, all hitting new highs.
Short Selling Data: The short selling ratios for major stocks varied, with NONGFU SPRING at 27.538% and BYD COMPANY at 9.979%, indicating significant market interest and activity.
<Midday Update> HSI Ends Midday at 26,463, Gaining 75 Points; HSTI Reaches 6,055, Up 66 Points; POP MART Falls More Than 7%; BABA, NTES, BAYZED HEALTH, and BRAINAURORA-B, TRANSTHERA-B Achieve New Highs
Market Performance: The HSI rose 75 points (0.3%) to 26,463, while the HSTI increased by 66 points (1.1%) to 6,055, and the HSCEI gained 31 points (0.3%) to 9,396.
Active Heavyweights: Notable stock movements included BABA (+2.8% to $155.4), XIAOMI (+1.2% to $55.8), and WUXI BIO (+5.5% to $38.48), while POP MART saw a significant decline of 7.2% to $257.
Short Selling Insights: BABA had a short selling ratio of 21.604% with $5.60B in short sales, while NTES had a high short selling ratio of 32.026% but still rose 1.5% to $240.
High Performers: BAYZED HEALTH surged by 40.3% to $9.54, BRAINAURORA-B increased by 36.3% to $10.22, and TRANSTHERA-B rose by 33.6% to $257.2, all hitting new highs.
CICC Identifies Stocks Expected to Qualify for Southbound Trading (Table)
Stock Predictions: CICC has listed stocks that may be included or excluded from the Hang Seng Composite Index, impacting their eligibility for Stock Connect investment.
Short Selling Data: Several companies, including China Foods and Country Garden, are experiencing significant short selling activity with varying ratios.
Stock Performance: The article highlights the percentage changes in stock prices for various companies, indicating both gains and losses.
Market Context: The information is relevant as it reflects current market trends and investor sentiment towards specific stocks in Hong Kong.
